OTCMKTS:ELLXF

Elixinol Global Stock Forecast, Price & News

$0.15

+0.01 (+3.57 %)

(As of 04/12/2021 03:44 PM ET)

Add

Compare

Today's Range

$0.14

Now: $0.15▼

$0.15

50-Day Range

$0.14

MA: $0.16▼

$0.20

52-Week Range

$0.09

Now: $0.15▼

$0.33

Volume75,960 shs

Average Volume220,530 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Elixinol Global Ltd. engages in the sale of nutraceutical and related hemp products. It manufactures and distributes industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products. The firm operates through the following segments: The company was founded by Paul Benhaim on September 4, 2017 and is headquartered in Sydney, Australia.

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Drug Manufacturers - Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:ELLXF

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.elixinolglobal.com

Phone(124) 044-4585

Employees76

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Headlines

Elixinol Global Limited (OTCMKTS:ELLXF) Short Interest Down 74.4% in March
March 27, 2021 | americanbankingnews.com

Proactive news headlines including Nanoveu, Kingston Resources, Theta Gold Mines and Elixinol Global Ltd
March 25, 2021 | ca.finance.yahoo.com

Elixinol Global positions itself as a leading pan-European CBD company by acquiring Germany’s CannaCare Health
March 14, 2021 | proactiveinvestors.com

Elixinol Global in trading halt with potential transaction news pending
March 4, 2021 | proactiveinvestors.com.au

"Build It And They Will Come" - North Star Holdings Unveils Cannabis Research Initiatives
February 26, 2021 | benzinga.com

Fog & Tree – Pioneering Cannabis Fragrance
February 10, 2021 | benzinga.com

2020: A Year In Review For The Psychedelic Renaissance
January 1, 2021 | benzinga.com

COVID-19 Proves The Cannabis Industry's Recession Resilience
December 25, 2020 | benzinga.com

Elixinol Global delighted as demand for its share purchase plan far exceeds target
December 16, 2020 | proactiveinvestors.com.au

Elixinol Global's share purchase plan receives strong early support with take up of more than 65% so far
December 3, 2020 | proactiveinvestors.com.au

Elixinol Global welcomes strong support for $8.2 million fundraise to accelerate growth strategy
November 19, 2020 | proactiveinvestors.com.au

Elixinol Global (ASX: EXL; OTC: ELLXF) to Present at the SNN Network Australia Virtual Event on Tuesday, November 10, 2020 (Wednesday, November 11 AEDT)
November 9, 2020 | finance.yahoo.com

Elixinol Launches 'Good Mood CBD Gummies' Just in Time for 2020 Election Day
October 30, 2020 | finance.yahoo.com

Green Rush Podcast: Fotmer CEO On Uruguay, A Sleeping Giant In The International Cannabis Space
October 24, 2020 | benzinga.com

Magic Johnson-Backed Uncle Bud's To Enter Asia Market In November
October 23, 2020 | benzinga.com

OTC Markets Group Welcomes Elixinol Global Limited to OTCQX
July 16, 2020 | www.bloomberg.com

New Cannabis Products: Kief, Chewing Gum And Sleep Capsules
July 10, 2020 | www.benzinga.com

Cannabis Stock Gainers And Losers From July 8, 2020
July 8, 2020 | www.msn.com

Elixinol LLC: Global CBD Brand Elixinol Announces Entry Into New Zealand Marketplace
June 23, 2020 | www.bloomberg.com

Elixinol LLC: Elixinol Global Significantly Expands European Operations
April 25, 2020 | www.bloomberg.com

See More Headlines

MarketRank^™

Overall MarketRank^™

0.82 out of 5 stars

Medical Sector

1177th out of 2,016 stocks

Drug Manufacturers - Specialty & Generic Industry

21st out of 61 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Elixinol Global.

4.1 Community Rank

Outperform Votes
Elixinol Global has received 67 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Elixinol Global has received 14 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Elixinol Global has received 82.72% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Elixinol Global and other stocks. Vote “Outperform” if you believe ELLXF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ELLXF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Elixinol Global does not currently pay a dividend.
Dividend Growth
Elixinol Global does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Elixinol Global insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$0.15

+0.01 (+3.57 %)

(As of 04/12/2021 03:44 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ELLXF News and Ratings via Email

Sign-up to receive the latest news and ratings for ELLXF and its competitors with MarketBeat's FREE daily newsletter.

Elixinol Global (OTCMKTS:ELLXF) Frequently Asked Questions

What stocks does MarketBeat like better than Elixinol Global?

Wall Street analysts have given Elixinol Global a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Elixinol Global wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Elixinol Global?

Elixinol Global saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 1,000 shares, a decline of 74.4% from the February 28th total of 3,900 shares. Based on an average trading volume of 224,600 shares, the short-interest ratio is currently 0.0 days.
View Elixinol Global's Short Interest.

How has Elixinol Global's stock been impacted by COVID-19 (Coronavirus)?

Elixinol Global's stock was trading at $0.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ELLXF stock has decreased by 27.5% and is now trading at $0.1450.
View which stocks have been most impacted by COVID-19.

Who are Elixinol Global's key executives?

Elixinol Global's management team includes the following people:

Oliver Horn, Group Chief Executive Officer & Executive Director
Ron Dufficy, Chief Financial Officer
Greg Smith, Global Chief Information Officer
Tom Siciliano, Chief Executive Officer-Americas
Ali Atcha, Chief Executive Officer-Europe & United Kingdom

Who are some of Elixinol Global's key competitors?

Some companies that are related to Elixinol Global include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics (CP1).
View all of ELLXF's competitors.

What is Elixinol Global's stock symbol?

Elixinol Global trades on the OTCMKTS under the ticker symbol "ELLXF."

How do I buy shares of Elixinol Global?

Shares of ELLXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Elixinol Global's stock price today?

One share of ELLXF stock can currently be purchased for approximately $0.15.

How many employees does Elixinol Global have?

Elixinol Global employs 76 workers across the globe.

What is Elixinol Global's official website?

The official website for Elixinol Global is www.elixinolglobal.com.

How can I contact Elixinol Global?

The company can be reached via phone at (124) 044-4585.

This page was last updated on 4/12/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Elixinol Global Stock Forecast, Price & News

Adding

Adding

Adding Elixinol Global Limited

Industry, Sector and Symbol

Debt

Price-To-Earnings

Sales & Book Value

Profitability

Miscellaneous

Headlines

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.1 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment